Hermetica Superfood Encyclopedia
The Short Answer
Ganoderma lingzhi contains polysaccharides (ganoderan) and triterpenoids (ganoderic acids) that exert immunomodulatory effects via TLR4-ERK signaling and inhibit tumor cell proliferation through cytotoxic and antioxidant mechanisms. In preclinical models, oral polysaccharide administration at 2.5 mg/kg enhanced immunoreactive cell recovery in cyclophosphamide-immunosuppressed mice, and triterpenoids demonstrated cytotoxicity with IC50 values of 10.0–46.3 μg/mL across multiple human cancer cell lines.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordGanoderma lingzhi benefits
Lingzhi — botanical close-up
Health Benefits
**Immunomodulation**
Polysaccharides (ganoderan) bind TLR4 receptors on macrophages, activating the ERK signaling cascade and upregulating cytokine expression in spleen cells, supporting both innate and adaptive immune responses.
**Antitumor Activity**
Triterpenoids such as ganoderic acids exhibit direct cytotoxicity against A549 (lung), MCF-7 (breast), PC3 (prostate), and HepG2 (liver) cancer cell lines with IC50 values ranging from 10.0 to 46.3 μg/mL, while polysaccharides provide complementary immunoreactive tumor suppression.
**Antioxidant Defense**
Beta-D-glucan side chains within ganoderan polysaccharides scavenge free radicals, and alkaloids such as lucidimine B demonstrate superior antioxidant activity compared to structural congeners, reducing oxidative stress at the cellular level.
**Hypoglycemic Effects**
Ganoderic acid triterpenoids inhibit the enzyme α-glucosidase, slowing postprandial carbohydrate digestion and reducing glucose absorption, suggesting a mechanism relevant to blood sugar regulation.
**Anti-inflammatory Action**
Triterpenoid fractions suppress LPS-induced nitric oxide production in RAW264.7 macrophages with IC50 values of 4.68–15.49 μM, indicating meaningful downregulation of pro-inflammatory mediators at physiologically relevant concentrations.
**Antiproliferative and Anticancer Alkaloid Effects**
The alkaloid lucidimine B exhibits antiproliferative activity in MCF-7 breast cancer cells with an EC50 of 0.27 ± 0.02 μmol/mL, a potency superior to its structural analogs, suggesting targeted disruption of cancer cell proliferation pathways.
**Immune Recovery Support**: Low-dose polysaccharide supplementation (2
5 mg/kg) in cyclophosphamide-treated mice accelerated the recovery of immunoreactive cells, indicating potential adjunctive utility in chemotherapy-associated immunosuppression contexts.
Origin & History
Natural habitat
Ganoderma lingzhi is a bracket fungus native to temperate and tropical forests across East Asia, particularly China, Japan, and Korea, where it grows on decaying hardwood trees, most commonly oak and plum. It has been cultivated in China for over 2,000 years, traditionally harvested from wild forest substrates and later grown on logs, sawdust, or grain-based media under controlled humidity and temperature. Modern commercial cultivation employs submerged fermentation in dextrose-ammonium chloride media at pH 3.5–7.0, significantly increasing polysaccharide yields to concentrations of up to 1.6 mg/mL.
“Lingzhi has been revered in Chinese medicine for more than 2,000 years, documented in the Shennong Bencao Jing (Divine Farmer's Classic of Materia Medica), where it was classified as a superior herb believed to tonify Qi, calm the mind, and promote longevity. In Imperial China, it was considered so rare and precious that it symbolized auspiciousness, immortality, and divine favor, often depicted in royal artwork, architecture, and religious iconography. Japanese traditional medicine (Kampo) adopted it as Reishi, using it to support immune vitality and cardiovascular health, while Korean traditional healers employed Yeongji to treat liver conditions and fatigue. Modern commercial cultivation, pioneered in Japan in the 1970s and subsequently scaled in China, democratized access to a fungus once available only to emperors, enabling the transition from folk remedy to globally marketed nutraceutical.”Traditional Medicine
Scientific Research
The evidence base for Ganoderma lingzhi consists predominantly of in vitro cell-culture studies and animal models, with no peer-reviewed randomized controlled trials (RCTs) in humans identified in the current literature synthesis. Preclinical data include dose-dependent reduction of sarcoma-180 tumor mass in mice following 10 days of oral polysaccharide administration, and restoration of immunoreactive cell populations in cyclophosphamide-immunosuppressed mice at 2.5 mg/kg polysaccharide doses. Over 140 triterpenoid compounds and more than 200 polysaccharide structures have been isolated and characterized, providing a rich phytochemical foundation, but the translation of these findings into human clinical outcomes remains unvalidated by controlled human trials. The overall quality of evidence is limited and exploratory; while mechanistic consistency across multiple in vitro and animal studies is encouraging, conclusions about efficacy in human disease cannot be drawn without adequately powered RCTs.
Preparation & Dosage
Traditional preparation
**Dried Basidiocarp Powder**
5–9 g/day in East Asian traditional practice, though no standardized human clinical dose is established
Traditional preparation involves drying and grinding the fruiting body; used in teas and decoctions at approximately 1..
**Hot Water Extract (Polysaccharide-Enriched)**
6 mg/mL; commercial extracts are often standardized to 10–40% polysaccharide content
Extracted via boiling or aqueous fermentation (pH 3.5–7.0 with dextrose-ammonium chloride medium) to yield polysaccharide concentrations up to 1..
**Alcohol/Ethanol Extract (Triterpenoid-Enriched)**
Lipophilic ganoderic acids require ethanol or organic solvent extraction; commercial products may be standardized to 1–6% triterpenes, with extraction yields of approximately 2.412% (RSD 1.079%).
**Dual-Extract Supplements**
Combining water and alcohol extractions captures both polysaccharide and triterpenoid fractions; found in commercial capsules, tablets, and tinctures with no universally accepted human dose established by RCT data.
**Submerged Fermentation Mycelium**
Industrial production using agitated, aerated liquid culture in defined media provides consistent polysaccharide yields; used in standardized pharmaceutical-grade preparations.
**Timing Note**
No clinical data exist to define optimal timing; traditional use often involves morning consumption as a tea or tonic, with supplements taken with meals to improve tolerability of the bitter triterpenoid fraction.
Nutritional Profile
Ganoderma lingzhi fruiting bodies contain a complex array of macronutrients and bioactives that vary considerably by origin, cultivation substrate, and processing method. Protein content ranges from 7 to 28.6% (water-soluble fraction), with the polysaccharide-protein complex GLPP averaging a molecular weight of 5.13 × 10^5 Da and notable amino acid constituents including aspartate at 8.49 mg/g. Mineral composition includes potassium (432 mg/100 g), phosphorus (225 mg/100 g), and copper (27 mg/100 g), alongside magnesium and calcium; a primary extract fraction reports 10.2% total metals. Moisture content ranges from 2.78% (dried preparations) to 47% (fresh fruiting body); ash content spans 1.21–18.7%. Key bioactive classes include over 200 polysaccharide structures, more than 140 triterpenoids (ganoderic acids, molecular mass 400–600 Da), sterols, adenosine nucleotides, lectins, and minor vitamins. Bioavailability of lipophilic triterpenoids is limited by poor water solubility, while polysaccharide absorption depends on molecular weight and gut microbiome activity.
How It Works
Mechanism of Action
Ganoderma lingzhi polysaccharides, particularly the beta-D-glucan fractions of ganoderan, act as pathogen-associated molecular pattern ligands that bind Toll-like receptor 4 (TLR4) on the surface of macrophages, initiating intracellular signaling through the extracellular signal-regulated kinase (ERK) pathway to upregulate cytokine gene expression and enhance immune cell activation. Triterpenoids, including ganoderic acids with molecular masses of 400–600 Da, inhibit α-glucosidase enzymatic activity and suppress LPS-induced nitric oxide synthase activity in macrophages, providing concurrent hypoglycemic and anti-inflammatory effects. The lipophilic ganoderic acid fraction also exerts direct cytotoxicity on malignant cell lines through mechanisms likely involving mitochondrial membrane disruption and pro-apoptotic pathway activation, as evidenced by IC50 values of 10.0–46.3 μg/mL across A549, MCF-7, PC3, and HepG2 lines. Alkaloids such as lucidimine B contribute antiproliferative effects in estrogen-receptor-positive breast cancer cells (EC50 0.27 ± 0.02 μmol/mL), while the combined polysaccharide-triterpenoid matrix delivers synergistic antioxidant, immunoreactive, and anticancer activity through complementary molecular targets.
Clinical Evidence
No large-scale human randomized controlled trials specific to Ganoderma lingzhi have been identified in the available literature, and the clinical evidence remains at the preclinical and mechanistic stage. Animal studies measuring tumor mass reduction (sarcoma-180 model), immune cell recovery in immunosuppressed mice, and macrophage cytokine modulation provide quantifiable outcomes, but effect sizes from these models cannot be directly extrapolated to human therapeutic doses or clinical endpoints. In vitro cytotoxicity IC50 values (10.0–46.3 μg/mL for cancer cell lines) and anti-inflammatory IC50 values (4.68–15.49 μM in RAW264.7 cells) offer mechanistic plausibility but do not constitute clinical proof of benefit. Confidence in clinical conclusions is therefore low, and Ganoderma lingzhi should be regarded as a promising candidate for further human investigation rather than an established therapeutic agent.
Safety & Interactions
Preclinical safety data from animal studies indicate a favorable short-term profile, with no significant adverse effects observed at polysaccharide doses of 2.5 mg/kg in mice during 10-day oral administration trials; however, robust human toxicology data are absent. No specific drug interaction studies are available in the reviewed literature, though the immunomodulatory activity of ganoderan polysaccharides raises theoretical concern for interactions with immunosuppressant medications (e.g., cyclosporine, tacrolimus) and potential additive effects when combined with anticoagulant or antiplatelet agents due to reported adenosine content. No contraindications have been formally established, but use during pregnancy and lactation is not recommended in the absence of human safety data, and individuals with autoimmune conditions should consult a healthcare provider before use. Maximum safe human doses have not been determined by clinical trial; traditional use at 1.5–9 g dried mushroom equivalent per day has not been associated with widespread reported toxicity, but this does not constitute established clinical safety validation.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ganoderma lucidumReishiLingzhiYeongjiMannentakeGlossy GanodermaLing Zhi
Frequently Asked Questions
What is Ganoderma lingzhi and how does it differ from Ganoderma lucidum?
Ganoderma lingzhi was formally reclassified as a distinct species from Ganoderma lucidum by Wu, Cao, and Dai in 2012 based on molecular phylogenetic analysis, though the two names are still used interchangeably in much of the scientific and commercial literature. Both species share similar bioactive profiles including polysaccharides and ganoderic acid triterpenoids, but G. lingzhi specifically refers to the cultivated East Asian strain most commonly used in traditional Chinese and Japanese medicine. Consumers and researchers should be aware that product labeling may not consistently distinguish between these taxonomically separate but chemically similar species.
What does Ganoderma lingzhi do for the immune system?
The beta-D-glucan polysaccharides in Ganoderma lingzhi bind to TLR4 receptors on macrophages, triggering ERK intracellular signaling that amplifies cytokine gene expression and activates immune effector cells. In animal studies, oral polysaccharide administration at 2.5 mg/kg significantly accelerated the recovery of immunoreactive cell populations in cyclophosphamide-immunosuppressed mice without producing significant side effects. These findings suggest immunomodulatory utility, particularly in contexts of chemotherapy-related immune depression, but human RCT data are not yet available to confirm or quantify this effect in people.
Can Ganoderma lingzhi help fight cancer?
Preclinical research demonstrates that ganoderic acid triterpenoids are cytotoxic to multiple human cancer cell lines—including A549 (lung), MCF-7 (breast), PC3 (prostate), and HepG2 (liver)—with IC50 values of 10.0–46.3 μg/mL, and oral polysaccharides reduced sarcoma-180 tumor mass in mice over 10 days. The alkaloid lucidimine B also showed potent antiproliferative activity in MCF-7 cells with an EC50 of 0.27 ± 0.02 μmol/mL. However, no human randomized controlled trials have demonstrated cancer treatment or prevention efficacy, and Ganoderma lingzhi must not be used as a substitute for established oncological therapies.
What is the recommended dosage for Ganoderma lingzhi supplements?
No standardized human clinical dose has been established through controlled trials for Ganoderma lingzhi. Traditional East Asian medicine has employed the dried fruiting body at approximately 1.5–9 g per day as a tea or decoction, and commercial extracts are often standardized to 10–40% polysaccharides or 1–6% triterpenoids. Consumers should follow manufacturer guidelines on standardized products and consult a healthcare provider, as effective and safe human doses remain formally undetermined by clinical research.
Is Ganoderma lingzhi safe to take, and does it have any drug interactions?
Short-term animal studies at 2.5 mg/kg polysaccharide doses report no significant adverse effects, and the mushroom has a long history of traditional use without widespread reported toxicity. However, its immunomodulatory activity creates theoretical interaction risks with immunosuppressant drugs such as cyclosporine and tacrolimus, and its adenosine content may potentiate anticoagulant or antiplatelet medications. Human safety data are limited, and use during pregnancy or lactation, or by individuals on immunosuppressive regimens, should only occur under medical supervision.
What are the active compounds in Ganoderma lingzhi that provide health benefits?
Ganoderma lingzhi contains two primary classes of bioactive compounds: polysaccharides (particularly ganoderan) that modulate immune function by binding to TLR4 receptors on macrophages, and triterpenoids such as ganoderic acids that demonstrate direct cytotoxic effects against cancer cells. These compounds work synergistically to support both innate and adaptive immune responses while activating important cellular signaling pathways like the ERK cascade. The specific composition and concentration of these active compounds can vary depending on growing conditions and extraction methods used in supplement production.
Which forms of Ganoderma lingzhi are most effective—whole mushroom, extract, or powder?
Hot-water extracts and standardized extracts are generally more bioavailable than whole dried mushroom powder because they concentrate the water-soluble polysaccharides and alcohol-soluble triterpenoids that drive the immunomodulatory and antitumor benefits. Dual extracts (combining both hot-water and alcohol extraction) capture a broader spectrum of active compounds and are often considered more effective than single-extraction methods. Whole mushroom powders contain these compounds but in lower concentrations and with reduced bioavailability, making standardized extracts typically the preferred form for therapeutic supplementation.
Who should prioritize Ganoderma lingzhi supplementation for immune and cellular health?
Individuals with compromised immune function, those undergoing conventional cancer treatment, and people over 50 seeking preventive immune support may benefit most from Ganoderma lingzhi due to its documented immunomodulating and antitumor properties. Those with chronic inflammatory conditions or chronic infections may also find value in its ability to upregulate cytokine expression and activate macrophage-mediated immune responses. However, individuals taking immunosuppressive medications or those scheduled for surgery should consult a healthcare provider before supplementation to avoid potential interactions with immune-modifying treatments.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ganoderma-lingzhi-ganoderma-lingzhi-sheng-h-wu-y-cao-yc-dai curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
